Status:
COMPLETED
A Study to Observe Characteristics of Rheumatoid Arthritis in Patients Using Infliximab (Study P04250)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Rheumatoid Arthritis
Eligibility:
All Genders
Brief Summary
This 14-week non-interventional study will observe patients with rheumatoid arthritis (RA) who are being treated with infliximab for the first time, in order to learn about their disease characteristi...
Eligibility Criteria
Inclusion
- Subject has been diagnosed with RA
- Physician has decided, with the subject's consent, to begin treatment with infliximab
- Written informed consent form signed by both the subject and the physician.
Exclusion
- Subjects who have previously been exposed to infliximab
Key Trial Info
Start Date :
December 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2008
Estimated Enrollment :
728 Patients enrolled
Trial Details
Trial ID
NCT00705289
Start Date
December 1 2005
End Date
September 1 2008
Last Update
July 30 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.